Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Avenue Therapeutics Inc. (ATXI) Insider Trading Activity
Healthcare • Biotechnology • 3 employees
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Total Value
-$182.64
Total Shares
-84
Average Trade Value
-$91.32
Most Active Insider
Kranzler Jay D
Total Activity: $137
Largest Single Transaction
$137
by Kranzler Jay D on Nov 5, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director
|
Dec 2, 2024 | 23 | $46 | 97 (-23.7%) | Sale | |
Director
|
Nov 5, 2024 | 61 | $137 | 559 (-10.9%) | Sale |